| 产品详情 |
| Edit |   |
| Product Name | b-Glucuronidase Inhibitor |
| Description | Purity ~99% (HPLC). An orally bioavailable trisubstituted thiourea compound that acts as a potent, uncompetitive and reversible inhibitor of bacterial b-glucuronidase activity (IC50 = 283nM; kcat/Km=0.0987s-1uM-1; Ki4nM in vitro assays against E. coli b-glucuronidase; EC50.7nM in b-glucuronidase expressing HB101 cells) with excellent selectivity over mammalian b-glucuronidases. Shown to directly target the 17-residue (360-376) loop structure that protects the active site of E. coli b-glucuronidase and alter its conformation. Displays negligible cytotoxicity toward both bacterial and mammalian epithelial cells (>100uM for HCT116, Caco-2 and CMT93 colon cancer cells) and offers protection against CPT-11 (50mg/kg, i.p., s.i.d. for 9 days)-induced toxicity in mice (10ug, p.o., b.i.d). Formula: C23H27N3O3S Molecular Weight: 425.5 Solubility: DMSO (50mg/ml) |
| Size | 10mg |
| Concentration | n/a |
| Applications | n/a |
| Other Names | b-Glucuronidase Inhibitor (1-((6,8-Dimethyl-2-oxo-1,2-dihydroquinolin-3-yl)methyl)-3-(4-ethoxyphenyl)-1-(2-hydroxyethyl)thiourea) |
| Gene, Accession, CAS # | n/a |
| Catalog # | 217209 |
| Price | |
| Order / More Info | b-Glucuronidase Inhibitor from UNITED STATES BIOLOGICAL |
| Product Specific References | n/a |
| 产品资料 |
|
|